Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Herman K Gold, MD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Massachusetts General Hospital
Boston, Massachusetts, United States
Aloke V Finn, MDAndrew Maree, MDEugene Pomerantsev, MD, PhDFarouc A Jaffer, MD, PhDGeorge T Lau, MDHerman K Gold, MDIgnacio Inglessis, MDIgor F Palacios, MDJae S Oh, BScJoseph Garasic, MDKenneth Rosenfield, MDLeon M Ptaszek, MDMaureen Daher, RNOwen C Raffel, MDRobert C. Leinbach, MDVishal Gupta, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- —
- Completion
- —
- Last update posted
- 22 May 2007
- Registered enrollment
- —
- Registry id
- NCT00476944
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.